NSABP Members' Area
  Password Protected - Access
  Limited to NSABP Participating
  Institutions Only

NSABP Foundation, Inc.

General NSABP Information
  Financial Conflicts of
     Interest Policy
  Coalition Comment:
  IOM Report Group Comment
  Contact the NSABP
  Pathology Section
  Future Meetings
  NSABP Newsletters
  Media Info on STAR

Clinical Trials Information
  Clinical Trials Overview
  Protocol Chart
  Never Say Lost

Treatment Trials Information
  Protocol B-51
  Protocol B-52
  Protocol B-53/S1207
  Protocol B-55/BIG 6-13

Prevention Trials Information
  Protocol P-1 - BCPT
  Protocol P-2 - STAR
  Protocol P-5

Scientific Publications

Related Web Sites

Medical Search Engines

To report problems, ask
questions or make comments,
please send e-mail to:

NSABP Clinical Trials Overview

Protocol B-10
A Protocol to Compare Combined Chemotherapy With and Without C. parvum + Hydrocortisone in The Management of Patients with Surgically Curable Breast Cancer

Specific Aims
The aim of this study is to test the following hypothesis:

C. parvum immunotherapy added to surgery and chemotherapy is more effective than surgery and chemotherapy alone; i.e., surgery with L-PAM + 5-FU + C. parvum + hydrocortisone (PF+CP) is more effective in prolonging disease-free survival and survival than surgery with L-PAM + 5-FU (PF).